A ctive transport of Na + and K + across the plasma membrane of several types of cells was known to exist by the early 1950s. Seminal work by Glynn, Skou, Post, and others (reviewed in Ref. 11) linked the transport of these two ions to one enzyme, now referred to as the Na + -K + -ATPase (or pump). This enzyme is ubiquitous in animal cells and appears to be essential for life as we know it. It is therefore not surprising that an enormous amount of work has been published on its transport characteristics, biochemistry, and structure. This review is concerned with its regulation.
The past decade has provided significant advances in our knowledge of the regulation of the Na + -K + pump but little understanding of its physiological purpose. Figure 1 illustrates the stoichiometry of the pump and some possible targets of regulatory changes in pump activity in the heart. In general, regulatory changes in Na + -K + pump current (I P ) are one part of an integrated, multifaceted control system that adjusts cardiac output to suit the needs of the organism. For example, activation of the sympathetic nervous system causes increases in the levels of circulating epinephrine and release of norepinephrine (NE) in the vicinity of heart cells. This results in activation of α-and β-adrenergic receptors that are coupled to changes in Na + , K + , Cl -, and Ca 2+ currents that affect the action potential, changes in pacemaker activity that increase heart rate, changes in excitation/contraction coupling that increase cardiac output, and changes in Na + -K + pump current. As suggested in Fig. 1 ] o ), particularly in small restricted volumes such as the t-system lumen or between tightly packed cells. Lastly, the 3Na + -for-2K + stoichiometry means that the Na + -K + pumps generate a net outward current, I P , which is a significant component of total net current during the cardiac action potential plateau phase. Hence regulatory changes in I P may directly affect the duration of the plateau phase, or indeed any electrical activity in the heart that is associated with small net current (e.g., pacemaking). With these possible functions in mind, we will review isoform-specific regulation of I P and point out cases in which the regulatory response of each isoform may or may not contribute to a particular function.
Isoforms of the Na

+ -K + pump
The Na + -K + pump is a multigene family of proteins. Each functional transporter comprises at least an α-and β-subunit, which may dimerize with another α-β complex. The α-subunit binds Na + and K + , hydrolyzes ATP, and binds ouabain, which blocks ATPase activity. Thus the functional properties of the Na + -K + pump are generally thought to reside in the α-subunit. However, there are multiple β-isoforms that may have specific functional roles that are not yet understood. There are at least three α-isoforms (14) , and in most species the α 1 -isoform has a much (100-fold) lower affinity for ouabain than the α 2 -or α 3 -isoform. The α 1 -isoform is most widely expressed, whereas the α 2 -or α 3 -isoform tends to be associated with excitable cells, though there are many exceptions. In heart, all three isoforms are expressed (14) , and guinea pig ventricular myocytes coexpress the α 1 -and α 2 -isoforms (9).
The first evidence for multiple isoforms in guinea pig myocytes came from data on I P blockade as a function of dihydroouabain (DHO) concentration (10) . The blockade data from Ref. 5 are shown in Fig. 2A . There are clearly two inhibitory sites with roughly a 100-fold difference in affinity. Gao et al. (5) reported that the two dissociation constants were 0.75 µM and 72 µM. This difference in affinity immediately suggested that the low DHO affinity pumps were the α 1 -isoform and the high DHO affinity pumps were either the α 2 -or α 3 -isoform. Gao et al. (9) used RNase protection assays and found mRNA for the α 1 -and α 2 -isoforms. Thus, in guinea pig ventricular myocytes, total I P is the sum of current contributed by the α 1 -isoform (I P1 ) plus that by the α 2 -isoform (I P2 ): I P = I P1 + I P2 .
The whole cell patch-clamp method we have used to study isoform-specific regulation of the Na + -K + pump is illustrated in Fig. 2B . A glass pipette is pressed against the membrane of an acutely isolated guinea pig ventricular myocyte. Suction is applied to the pipette, causing it to seal to the membrane, and with further suction, the patch of membrane beneath the tip ruptures. Within ~5 min, the solution in the pipette News Physiol. Sci. Fig. 2A are at 5 µM DHO, which blocks essentially all transport by the α 2 -isoform with little effect on the α 1 -isoform, and 1 mM DHO, which blocks essentially all transport by both the α 1 -and α 2 -isoforms. Thus 5 µM DHO was used to determine I P2 , and 1 mM DHO was used to determine I P = I P1 + I P2 , then I P1 = I P -I P2 . In some experiments, 5 µM DHO was continuously superfused; then when 1 mM DHO was added, the resulting ∆I P approximately equaled I P1 .
Physical factors affecting the Na
+ -K + pump
Regulation of the Na + -K + pump may occur because of autonomic input, which initiates a signal transduction cascade to alter pump activity, or physical factors, whose normal physiological variation directly alters pump activity. Figure 3 summarizes the effects of the physical environment on the α 1 -and α 2 -isoforms in guinea pig ventricular myocytes. The graphs show the normalized activation curves, whereas the numbers below represent half-maximal activation for each isoform (5 The last panel in Fig. 3 shows that both isoforms depend on membrane voltage (V m ). Gadsby and Nakao (1) first measured the voltage dependence of total pump current (I P -V m ) in guinea pig myocytes. Rakowski et al. (12) showed that the voltage dependence arises because Na + is released to the extracellular space in a long narrow channel within the pump protein. In the Na + release state of the pump cycle, the intracellular end of this channel is closed, so when the Na + comes off of its binding site, it can only move along the channel toward the extracellular space. However, the closed end of the channel is essentially at the same voltage as the cell. Thus the more negative the intracellular voltage, the longer the time that Na + spends in the channel, where it can rebind and inhibit the forward cycle of the pump. Shi (13) separately measured the V m dependence of I P1 and I P2 and found that they were similar but not identical. Although I P1 -V m and I P2 -V m are normally similar, autonomic input can shift I P1 -V m (see below), so voltage dependence is a physical factor that can be altered by autonomic input. Since outward current increases as transmembrane voltage depolarizes, this is a form of negative feedback that tends to directly hyperpolarize the resting voltage while increasing the Na + and K + gradients that determine the resting voltage. With regard to the action potential, I P has many similarities to most K + currents: it is outward, increases on depolarization, and tends to cause hyperpolarization, which in turn causes it to decrease. However, on the time scale of a cardiac action potential, there is no significant delay in voltage-mediated changes in I P .
Of these physical factors, [Na + ] i is the most pervasive effector of I P . Indeed, at steady state, Na + efflux by the Na + -K + pump must equal Na + influx through all other channels and transporters. Consequently, regulatory changes in I P that do not alter influx will not alter steady-state I P ; instead, [Na + ] i will change until efflux equals influx. Thus autonomic input that appears to regulate I P can only cause transient changes unless it also modifies Na + influx. One must therefore consider the entire spectrum of regulatory effects on electrical activity. If I P is uniquely affected, then [Na + ] i , or perhaps [Ca 2+ ] i , is actually the target. However, if Na + influx is being altered, for example by a change in heart rate, at the same time that I P is changed, then the change in I P may persist at steady state, and in this circumstance it could affect some of the other targets suggested in Fig. 1 . Autonomic input to the heart does indeed have multifactorial effects, so as outlined above, there may be more than one functional target for regulation of I P . The presence of more than one isoform and the specific effects on each isoform are certainly consistent with more than one functional target. Figure 4 summarizes the effects of sympathetic or parasympathetic activation on the α 1 -and α 2 -isoforms of the Na + -K + pumps in guinea pig ventricular myocytes.
Sympathetic activation causes an increase in NE, which activates β-adrenergic receptors (β-R). The β-R are coupled through a G s protein to activation of the adenylyl cyclase and production of cAMP. The regulatory domain of phosphokinase A (PKA) binds cAMP, which activates the kinase. All β-effects on the Na + -K + pumps are on the α 1 -isoform through PKAmediated phosphorylation; however, following PKA activation, the steps that lead to the changes in I P1 are unknown. ] i response of I P1 results in no change in current during the AP plateau (~0 mV); hence this response is designed to not affect plateau duration.
NE also binds to α 1 -adrenergic receptors (α 1 -R), which are coupled by a G q protein to activation of phospholipase C (PLC). PLC cleaves phosphatidylinositol 4,5-diphosphate (PIP 2 ) lipids to produce membrane-bound diacylglycerol (DAG) and cytoplasmic inositol 1,4,5-trisphosphate (IP 3 ). IP 3 causes Ca 2+ release from intracellular stores, and the resulting increase in [Ca 2+ ] i stabilizes the interaction of phosphokinase C (PKC) with the plasma membrane, where it is activated by DAG. All α-effects on the Na + -K + pump are on the α 2 -isoform through PKC-mediated phosphorylation (8, 15) ; however, as was the case with PKA, following PKC activation, the steps leading to an increase in I P2 are unknown. Because activation of PKC is [Ca 2+ ] i dependent, so is the α 1 -R-mediated increase in I P2 . At any given [Ca 2+ ] i , a sufficiently high concentration of NE causes a 42% increase in I P2 at all physiologically relevant voltages. However, at a given concentration of NE, for example 10 nM, there is no effect on I P2 if [Ca 2+ ] i is 15 nM, whereas there is a 30% increase in I P2 if [Ca 2+ ] i is 1.4 µM (15). Inhibition of PKC with staurosporine abolishes all α 1 -R effects on I P2 (15) , but the nonspecific kinase inhibitor H7 has no effect on I P2 in the absence of α 1 -R activation, suggesting that basal activity of PKC is low (8) . Conversely, when PKC is directly activated with the phorbol ester phorbol 12-myristate 13-acetate (PMA), the maximal 88% increase in I P2 is twice as large as that caused by α 1 -R activation (8) . Moreover, in the presence of maximal α 1 -R activation, addition of PMA causes a further increase in I P2 that is not additive; rather, the maximal I P2 is still 88% greater than basal I P2 . This suggests that the α 1 -receptors are coupled to a specific pool of PKC that is a subset of total PKC, which is activated by PMA. The limited coupling may be through colocalization in a membrane domain such as caveoli. It also suggests the existence of a second pool of PKC that is also coupled to I P2 , but we do not know the physiological effectors that regulate this pool.
Activation of the parasympathetic nervous system causes the release of acetylcholine (ACh) in the vicinity of cardiac myocytes. ACh binds to the muscarinic ACh receptor (ACh-R) FIGURE 2. The effect of the specific inhibitor dihydroouabain (DHO) on the Na + -K + pump current and the method of using DHO to measure isoformspecific regulatory effects on pump current. Top: normalized inhibition of the Na + -K + pump current (∆I P ) in guinea pig ventricular myocytes as a function of DHO concentration. The existence of two DHO-binding sites, whose dissociation constants differed by ~100-fold, was the first evidence for 2 isoforms of the Na + -K + pumps in these cells. The best fit curve is the sum of 2 first-order binding curves (shown as dashed lines), with the α 1 -isoform generating ~65% of the total current in normal conditions and having a dissociation constant of 72 µM, and the α 2 -isoform generating the remaining 35% of the current and having a dissociation constant of 0.75 µM. The vertical dashed lines represent 5 µM DHO, which inhibits the current generated by the α 2 -isoform with little effect on that due to the α 1 -isoform, and 1 mM DHO, which inhibits the current generated by both isoforms. Data are from Gao et al. (5) . Bottom: whole cell patch-clamp method of recording Na + -K + pump current in acutely isolated cardiac myocytes. As with most advances in biomedical knowledge, our understanding of isoform-specific regulation of the Na + -K + pumps was preceded by technological advances: first by the development of the whole cell patch-clamp that allows control of the many variables that affect the Na + -K + pumps, and second by improved techniques for acutely isolating cardiac myocytes. To separately measure the contributions of the α 1 -and α 2 -isoforms, either 5 µM or 1 mM DHO was used to inhibit either I P2 or I P1 + I P2 , respectively. V C , command voltage; I h , holding current.
to generally reduce heart rate and cardiac output. The ACh-R is coupled through a G i protein to inhibit adenylyl cyclase activity, reduce cAMP, and thus inhibit PKA. The effect on the Na + -K + pumps is to reverse the β-R-mediated effects on I P1 (6). In the absence of β-R activation, ACh has no effect on I P1 , suggesting that basal PKA activity is low. Also, direct inhibition of PKA with the synthetic peptide PKI has no effect on I P1 in the absence of β-R activation but prevents all β-effects (2, 3), consistent with low basal PKA activity. We do not know if there are direct effects of ACh-R activation on the PKC-mediated increase in I P2 . However, since PKC activation depends on [Ca 2+ ] i , there are almost surely indirect effects through a reduction in Ca 2+ influx, a reduction in [Ca 2+ ] i , and at least partial reversal of PKC activation.
In an organism, activation of the sympathetic or parasympathetic nervous system will have effects on cardiac myocytes that alter some of the physical factors regulating I P (see Fig. 3 P2 were not indirect and that they were not through a change in the affinity of the isoform for either intracellular Na + or extracellular K + . Thus, although the mechanisms coupling PKA→I P1 and PKC→I P2 are not known, they appear to be through signal transduction cascades that directly target each isoform. The kinases could either directly phosphorylate the pump proteins and alter ATPase activity of either the α 1 -or α 2 -isoform or they could phosphorylate regulatory proteins to initiate a cascade of events that are targeted to alter either I P1 or I P2 .
The PKA-mediated, high-[Ca 2+ ] i voltage shift in I P1 -V m is particularly interesting. The voltage-independent effects of either PKA or PKC can be either a change in ATPase activity with a fixed number of pump proteins or a change in the number of pump proteins with a fixed ATPase activity, or perhaps both. Neither mechanism, however, can explain a voltage shift. As described earlier, the voltage dependence of I P is due to the release of extracellular Na + into a voltage well (12) . The more negative the voltage at the bottom of the well, the longer the released Na + stays there; hence the greater the probability of rebinding, which slows the forward cycle of the pump. Direct PKA-mediated phosphorylation of the α 1 -isoform could change its free energy and thus the affinity for extracellular Na + . A reduction in affinity would require a more negative voltage to produce the same probability of rebinding; thus the result would be a negative shift in I P1 -V m . However, intracellular Ca 2+ is also involved. Binding of Ca 2+ near the intracellular end of the well could cause the local voltage at the bottom of the well to become more positive, and this would also result in a negative shift in I P1 -V m . At this stage, we can only hypothesize possible mechanisms. Elucidation of these final steps, however, may be very important to our understanding of regulation, not only in the heart, but also to our understanding the diverse effects of PKA and PKC on I P in different tissues.
Summary
Those of us who were educated after the dark ages when digital computers did not exist but after the enlightened age of Windows were taught about logic circuits. These circuits are constructed by the interconnections of and, not and, or, and nor gates. There are some remarkable similarities between the manner in which the cell computes its responses and these logic circuits. For example, voltage shifted I P1 = (Ca 2+ ) and (PKA); basal I P1 = (not Ca 2+ ) and (not PKA); inhibited I P1 = (not Ca 2+ ) and (PKA). Going back one step, PKA = (β-R) and (not ACh-R), and the logic circuit for Ca 2+ is even more elaborate, with the response of I P1 probably being part of one feedback control loop. Thus each of our cells is not only a miniature biochemical factory, it is also a miniature computer. The logic gates within a cell are the proteins that comprise the signal transduction cascades. Because each cascade generally involves a number of steps, it is relatively easy for a cell to reprogram its response when confronted with chronic changes in demands and for different cell types to program different responses to the same environment.
The ability to have specific responses is undoubtedly critical to cell function. For example, sympathetic activation increases NE, but the response of the heart to NE should not be the same as the response of the kidney. Every step in the signal transduction cascades linking NE to changes in Na + -K + pump activity provides a means of uniquely determining the response. There are several different receptors with multiple isoforms. Each receptor is coupled to a specific G protein that can be either stimulatory or inhibitory to PKA or PKC. If the targets of PKA or PKC phosphorylation are regulatory proteins, then different cell types can express different proteins.
But even if the targets are the Na + -K + pumps, each cell type can express a different combination of isoforms and thus possess a unique response. Physiological regulation of the Na + -K + pump is obviously complex and not well understood. One must start with the isoform of the pump and work back through the signal transduction cascade, identifying each isoform of each protein involved. When this information is ultimately available, some generalizations will likely become possible. But at this stage of our understanding, the appropriate generalization is that we should not generalize regulatory responses recorded in one type of cell to other types of cells.
